Latest / Investor Connect Podcast
Investor Connect 883: TEN Connect May 2026 - Part 3
In this episode of Investor Connect, we hear a pitch from Aether on addressing the global opioid epidemic with ATX-1209, a neuromodulator designed to modulate the mu-opioid receptor by suppressing dependence signals while preserving analgesic benefit when used alongside opioids, with additional development plans for opioid use disorder and neonatal opioid withdrawal syndrome (NOWS). The team cites completed human safety work, clean toxicology, and consistent animal data across species, along with validation from neuroscientist Dr. Phil Skolnick, and outlines a stage-gated, capital-efficient…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.